{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T00:49:53Z","timestamp":1792111793908,"version":"4.4.0"},"reference-count":35,"publisher":"Springer Science and Business Media LLC","issue":"12","license":[{"start":{"date-parts":[[2025,10,18]],"date-time":"2025-10-18T00:00:00Z","timestamp":1760745600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,10,18]],"date-time":"2025-10-18T00:00:00Z","timestamp":1760745600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Arch Microbiol"],"published-print":{"date-parts":[[2025,12]]},"DOI":"10.1007\/s00203-025-04526-6","type":"journal-article","created":{"date-parts":[[2025,10,18]],"date-time":"2025-10-18T10:11:45Z","timestamp":1760782305000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["Intranasal phage therapy overcomes antibody neutralization challenges in pulmonary Pseudomonas aeruginosa infections"],"prefix":"10.1007","volume":"207","author":[{"given":"Dhammika Leshan","family":"Wannigama","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jingping","family":"Shao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongya","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yangzhong","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cameron","family":"Hurst","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter N.","family":"Monk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohan","family":"Amarasiri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Phatthranit","family":"Phattharapornjaroen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"William Graham Fox","family":"Ditcham","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thin Sandi","family":"Htun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sirirat","family":"Luk-in","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoshitaka","family":"Shimotai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Natharin","family":"Ngamwongsatit","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hitoshi","family":"Ishikawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naveen Kumar Devanga","family":"Ragupathi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel","family":"Pletzer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Talerngsak","family":"Kanjanabuch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aisha","family":"Khatib","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kazuhiko","family":"Miyanaga","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Longzhu","family":"Cui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kenji","family":"Shibuya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul G.","family":"Higgins","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anthony","family":"Kicic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Parichart","family":"Hongsing","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jinxin","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuichi","family":"Abe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroshi","family":"Hamamoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,10,18]]},"reference":[{"key":"4526_CR1","doi-asserted-by":"publisher","DOI":"10.3390\/molecules30153132","author":"O Alessa","year":"2025","unstructured":"Alessa O, Aiba Y, Arbaah M, Hidaka Y, Watanabe S, Miyanaga K, Wannigama DL, Cui L (2025) Synthetic and functional engineering of bacteriophages: approaches for tailored bactericidal, diagnostic, and delivery platforms. Molecules. https:\/\/doi.org\/10.3390\/molecules30153132","journal-title":"Molecules"},{"issue":"1","key":"4526_CR2","doi-asserted-by":"publisher","first-page":"2993","DOI":"10.1038\/s41467-024-47192-w","volume":"15","author":"JD Berkson","year":"2024","unstructured":"Berkson JD, Wate CE, Allen GB, Schubert AM, Dunbar KE, Coryell MP, Sava RL, Gao Y, Hastie JL, Smith EM (2024) Phage-specific immunity impairs efficacy of bacteriophage targeting vancomycin resistant Enterococcus in a murine model. Nat Commun 15(1):2993","journal-title":"Nat Commun"},{"key":"4526_CR3","doi-asserted-by":"publisher","DOI":"10.1016\/j.medj.2024.05.017","author":"M Bernabeu-Gimeno","year":"2024","unstructured":"Bernabeu-Gimeno M et al (2024) Neutralizing antibodies after nebulized phage therapy in cystic fibrosis patients. Med. https:\/\/doi.org\/10.1016\/j.medj.2024.05.017","journal-title":"Med"},{"issue":"8","key":"4526_CR4","doi-asserted-by":"publisher","first-page":"959","DOI":"10.1080\/17425247.2017.1252329","volume":"14","author":"E Bodier-Montagutelli","year":"2017","unstructured":"Bodier-Montagutelli E, Morello E, l\u2019Hostis G, Guillon A, Dalloneau E, Respaud R, Pallaoro N, Blois H, Vecellio L, Gabard J (2017) Inhaled phage therapy: a promising and challenging approach to treat bacterial respiratory infections. Expert Opin Drug Deliv 14(8):959\u2013972","journal-title":"Expert Opin Drug Deliv"},{"key":"4526_CR5","doi-asserted-by":"publisher","DOI":"10.3390\/antibiotics13090870","author":"L Cui","year":"2024","unstructured":"Cui L, Watanabe S, Miyanaga K, Kiga K, Sasahara T, Aiba Y, Tan X-E, Veeranarayanan S, Thitiananpakorn K, Nguyen HM, Wannigama DL (2024) A comprehensive review on phage therapy and phage-based drug development. Antibiotics. https:\/\/doi.org\/10.3390\/antibiotics13090870","journal-title":"Antibiotics"},{"issue":"5","key":"4526_CR6","doi-asserted-by":"publisher","first-page":"2000","DOI":"10.1002\/med.21572","volume":"39","author":"K D\u0105browska","year":"2019","unstructured":"D\u0105browska K (2019) Phage therapy: what factors shape phage pharmacokinetics and bioavailability? Systematic and critical review. Med Res Rev 39(5):2000\u20132025","journal-title":"Med Res Rev"},{"issue":"21","key":"4526_CR7","doi-asserted-by":"publisher","first-page":"12551","DOI":"10.1128\/JVI.02043-14","volume":"88","author":"K D\u0105browska","year":"2014","unstructured":"D\u0105browska K, Miernikiewicz P, Piotrowicz A, Hodyra K, Owczarek B, Lecion D, Ka\u017amierczak Z, Letarov A, G\u00f3rski A (2014) Immunogenicity studies of proteins forming the T4 phage head surface. J Virol 88(21):12551\u201312557","journal-title":"J Virol"},{"issue":"8","key":"4526_CR8","doi-asserted-by":"publisher","first-page":"1357","DOI":"10.1038\/s41591-021-01403-9","volume":"27","author":"RM Dedrick","year":"2021","unstructured":"Dedrick RM, Freeman KG, Nguyen JA, Bahadirli-Talbott A, Smith BE, Wu AE, Ong AS, Lin CT, Ruppel LC, Parrish NM (2021) Potent antibody-mediated neutralization limits bacteriophage treatment of a pulmonary Mycobacterium abscessus infection. Nat Med 27(8):1357\u20131361","journal-title":"Nat Med"},{"issue":"12","key":"4526_CR9","doi-asserted-by":"publisher","first-page":"3800","DOI":"10.3390\/jcm9123800","volume":"9","author":"M Garcia-Clemente","year":"2020","unstructured":"Garcia-Clemente M, de la Rosa D, M\u00e1iz L, Gir\u00f3n R, Blanco M, Olveira C, Canton R, Martinez-Garc\u00eda MA (2020) Impact of Pseudomonas aeruginosa infection on patients with chronic inflammatory airway diseases. J Clin Med 9(12):3800","journal-title":"J Clin Med"},{"issue":"5430","key":"4526_CR10","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1038\/246221a0","volume":"246","author":"MR Geier","year":"1973","unstructured":"Geier MR, Trigg ME, Merril CR (1973) Fate of bacteriophage lambda in non-immune germ-free mice. Nature 246(5430):221\u2013223","journal-title":"Nature"},{"key":"4526_CR11","doi-asserted-by":"publisher","first-page":"186","DOI":"10.1016\/j.copbio.2020.11.011","volume":"68","author":"K Gembara","year":"2021","unstructured":"Gembara K, D\u0105browska K (2021) Phage-specific antibodies. Curr Opin Biotechnol 68:186\u2013192","journal-title":"Curr Opin Biotechnol"},{"issue":"2","key":"4526_CR12","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1089\/phage.2020.0004","volume":"1","author":"K Hodyra-Stefaniak","year":"2020","unstructured":"Hodyra-Stefaniak K, Ka\u017amierczak Z, Majewska J, Sillankorva S, Miernikiewicz P, Mi\u0119dzybrodzki R, G\u00f3rski A, Azeredo J, Lavigne R, Lecion D (2020) Natural and induced antibodies against phages in humans: induction kinetics and immunogenicity for structural proteins of PB1-related phages. Phage 1(2):91\u201399","journal-title":"Phage"},{"issue":"2","key":"4526_CR13","first-page":"173","volume":"5","author":"C Inchley","year":"1969","unstructured":"Inchley C (1969) The activity of mouse Kupffer cells following intravenous injection of T4 bacteriophage. Clin Exp Immunol 5(2):173","journal-title":"Clin Exp Immunol"},{"key":"4526_CR14","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2021.699054","volume":"12","author":"S Kaur","year":"2021","unstructured":"Kaur S, Kumari A, Kumari Negi A, Galav V, Thakur S, Agrawal M, Sharma V (2021) Nanotechnology based approaches in phage therapy: overcoming the pharmacological barriers. Front Pharmacol 12:699054","journal-title":"Front Pharmacol"},{"issue":"3","key":"4526_CR15","doi-asserted-by":"publisher","first-page":"577","DOI":"10.3181\/00379727-98-24112","volume":"98","author":"R Keller","year":"1958","unstructured":"Keller R, Engley FB Jr (1958) Fate of bacteriophage particles introduced into mice by various routes. Proc Soc Exp Biol Med 98(3):577\u2013580","journal-title":"Proc Soc Exp Biol Med"},{"key":"4526_CR16","doi-asserted-by":"publisher","DOI":"10.3390\/ijtm5020017","author":"Y Kuramasu","year":"2025","unstructured":"Kuramasu Y, Suzuki Y, Akaneya D, Okuma Y, Tsujimoto Y, Ishizawa D, Moriya K, Hongsing P, Amarasiri M, Hurst C, Higgins PG, Shibuya K, Kicic A, Shimotai Y, Hamamoto H, Wannigama DL, Abe S (2025) Identifying high-risk bacteria with active nasal swab surveillance in intensive care units to prevent ventilator-associated pneumonia. Int J Transl Med. https:\/\/doi.org\/10.3390\/ijtm5020017","journal-title":"Int J Transl Med"},{"issue":"1","key":"4526_CR17","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-025-05667-w","volume":"15","author":"M Laowansiri","year":"2025","unstructured":"Laowansiri M, Suwanchote S, Wannigama DL, Badavath VN, Hongsing P, Edwards SW, Suratannon N, Chatchatee P, Lertpichitkul P, Rerknimitr P, Chantawarangul K, Chatproedprai S, Wananukul S, Thammahong A, Plongla R, Chanachaithong P, Chavasiri W, Chatsuwan T, Chiewchengchol D (2025) Monolaurin inhibits antibiotic-resistant Staphylococcus aureus in patients with atopic dermatitis. Sci Rep 15(1):23180","journal-title":"Sci Rep"},{"issue":"1","key":"4526_CR18","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-025-97424-2","volume":"15","author":"S Luk-In","year":"2025","unstructured":"Luk-In S, Phopin K, Bangmuangngam S, Chatsuwan T, Wannigama DL, Shein AMS, Plongla R, Lawung R, Yainoy S, Eiamphungporn W, Chatupheeraphat C, Tantimongcolwat T (2025) Inhibitory effects of benzyl isothiocyanate on widespread mcr-1-harbouring IncX4 plasmid transfer. Sci Rep 15(1):12892","journal-title":"Sci Rep"},{"key":"4526_CR19","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2019.02607","volume":"10","author":"J Majewska","year":"2019","unstructured":"Majewska J, Ka\u017amierczak Z, Lahutta K, Lecion D, Szymczak A, Miernikiewicz P, Drapa\u0142a J, Harhala M, Marek-Bukowiec K, J\u0119druchniewicz N (2019) Induction of phage-specific antibodies by two therapeutic staphylococcal bacteriophages administered per os. Front Immunol 10:2607","journal-title":"Front Immunol"},{"key":"4526_CR20","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1016\/j.cis.2017.05.014","volume":"249","author":"DJ Malik","year":"2017","unstructured":"Malik DJ, Sokolov IJ, Vinner GK, Mancuso F, Cinquerrui S, Vladisavljevic GT, Clokie MR, Garton NJ, Stapley AG, Kirpichnikova A (2017) Formulation, stabilisation and encapsulation of bacteriophage for phage therapy. Adv Colloid Interface Sci 249:100\u2013133","journal-title":"Adv Colloid Interface Sci"},{"key":"4526_CR21","doi-asserted-by":"publisher","DOI":"10.1183\/16000617.0121-2022","author":"G Mitropoulou","year":"2022","unstructured":"Mitropoulou G, Koutsokera A, Csajka C, Blanchon S, Sauty A, Brunet J-F, von Garnier C, Resch G, Guery B (2022) Phage therapy for pulmonary infections: lessons from clinical experiences and key considerations. Eur Respir Rev. https:\/\/doi.org\/10.1183\/16000617.0121-2022","journal-title":"Eur Respir Rev"},{"issue":"7","key":"4526_CR22","doi-asserted-by":"publisher","first-page":"351","DOI":"10.3390\/v10070351","volume":"10","author":"F Oechslin","year":"2018","unstructured":"Oechslin F (2018) Resistance development to bacteriophages occurring during bacteriophage therapy. Viruses 10(7):351","journal-title":"Viruses"},{"issue":"5","key":"4526_CR23","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pbio.3002119","volume":"21","author":"A Petrovic Fabijan","year":"2023","unstructured":"Petrovic Fabijan A, Iredell J, Danis-Wlodarczyk K, Kebriaei R, Abedon ST (2023) Translating phage therapy into the clinic: recent accomplishments but continuing challenges. PLoS Biol 21(5):e3002119","journal-title":"PLoS Biol"},{"issue":"7","key":"4526_CR24","doi-asserted-by":"publisher","first-page":"4005","DOI":"10.1128\/AAC.02388-13","volume":"58","author":"DD Semler","year":"2014","unstructured":"Semler DD, Goudie AD, Finlay WH, Dennis JJ (2014) Aerosol phage therapy efficacy in Burkholderia cepacia complex respiratory infections. Antimicrob Agents Chemother 58(7):4005\u20134013","journal-title":"Antimicrob Agents Chemother"},{"key":"4526_CR25","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2023.115793","volume":"168","author":"AMS Shein","year":"2023","unstructured":"Shein AMS, Wannigama DL, Hurst C, Monk PN, Amarasiri M, Badavath VN, Phattharapornjaroen P, Ditcham WGF, Ounjai P, Saethang T (2023) Novel intranasal phage-CaEDTA-ceftazidime\/avibactam triple combination therapy demonstrates remarkable efficacy in treating Pseudomonas aeruginosa lung infection. Biomed Pharmacother 168:115793","journal-title":"Biomed Pharmacother"},{"issue":"1","key":"4526_CR26","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-024-79924-9","volume":"14","author":"AMS Shein","year":"2024","unstructured":"Shein AMS, Wannigama DL, Hurst C, Monk PN, Amarasiri M, Wongsurawat T, Jenjaroenpun P, Phattharapornjaroen P, Ditcham WGF, Ounjai P, Saethang T, Chantaravisoot N, Badavath VN, Luk-in S, Nilgate S, Rirerm U, Srisakul S, Kueakulpattana N, Laowansiri M, Rad SMAH, Wacharapluesadee S, Rodpan A, Ngamwongsatit N, Thammahong A, Ishikawa H, Storer RJ, Leelahavanichkul A, Ragupathi NKD, Classen AY, Kanjanabuch T, Pletzer D, Miyanaga K, Cui L, Hamamoto H, Higgins PG, Kicic A, Chatsuwan T, Hongsing P, Abe S (2024) Phage cocktail amikacin combination as a potential therapy for bacteremia associated with carbapenemase producing colistin resistant Klebsiella pneumoniae. Sci Rep 14(1):28992","journal-title":"Sci Rep"},{"issue":"4","key":"4526_CR27","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0153777","volume":"11","author":"S Singla","year":"2016","unstructured":"Singla S, Harjai K, Katare OP, Chhibber S (2016) Encapsulation of bacteriophage in liposome accentuates its entry in to macrophage and shields it from neutralizing antibodies. PLoS One 11(4):e0153777","journal-title":"PLoS One"},{"issue":"1","key":"4526_CR28","doi-asserted-by":"publisher","DOI":"10.1038\/s44259-024-00045-4","volume":"2","author":"AM Sithu Shein","year":"2024","unstructured":"Sithu Shein AM, Hongsing P, Khatib A, Phattharapornjaroen P, Miyanaga K, Cui L, Shibuya K, Amarasiri M, Monk PN, Kicic A, Chatsuwan T, Higgins PG, Abe S, Wannigama DL (2024) Phage therapy could be key to conquering persistent bacterial lung infections in children. NPJ Antimicrob Resist 2(1):31","journal-title":"NPJ Antimicrob Resist"},{"issue":"3","key":"4526_CR29","doi-asserted-by":"publisher","first-page":"e02071","DOI":"10.1128\/aac.02071-21","volume":"66","author":"GA Suh","year":"2022","unstructured":"Suh GA, Lodise TP, Tamma PD, Knisely JM, Alexander J, Aslam S, Barton KD, Bizzell E, Totten KM, Campbell JL (2022) Considerations for the use of phage therapy in clinical practice. Antimicrob Agents Chemother 66(3):e02071-02021","journal-title":"Antimicrob Agents Chemother"},{"issue":"7","key":"4526_CR30","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0307079","volume":"19","author":"N Sutnu","year":"2024","unstructured":"Sutnu N, Chancharoenthana W, Kamolratanakul S, Phuengmaung P, Singkham-In U, Chongrak C, Montathip S, Wannigama DL, Chatsuwan T, Ounjai P, Schultz MJ, Leelahavanichkul A (2024) Bacteriophages isolated from mouse feces attenuates pneumonia mice caused by Pseudomonas aeruginosa. PLOS ONE 19(7):e0307079","journal-title":"PLOS ONE"},{"issue":"1","key":"4526_CR31","doi-asserted-by":"publisher","DOI":"10.3390\/v11010010","volume":"11","author":"JD Van Belleghem","year":"2018","unstructured":"Van Belleghem JD, D\u0105browska K, Vaneechoutte M, Barr JJ, Bollyky PL (2018) Interactions between bacteriophage, bacteria, and the mammalian immune system. Viruses 11(1):10","journal-title":"Viruses"},{"issue":"1","key":"4526_CR32","doi-asserted-by":"publisher","DOI":"10.1186\/s12951-024-02576-4","volume":"22","author":"H Wang","year":"2024","unstructured":"Wang H, Yang Y, Xu Y, Chen Y, Zhang W, Liu T, Chen G, Wang K (2024) Phage-based delivery systems: engineering, applications, and challenges in nanomedicines. J Nanobiotechnol 22(1):365","journal-title":"J Nanobiotechnol"},{"issue":"1","key":"4526_CR33","doi-asserted-by":"publisher","DOI":"10.1186\/s12916-025-04009-x","volume":"23","author":"DL Wannigama","year":"2025","unstructured":"Wannigama DL, Hurst C, Monk PN, Hartel G, Ditcham WGF, Hongsing P, Phattharapornjaroen P, Ounjai P, Torvorapanit P, Jutivorakool K, Luk-in S, Nilgate S, Rirerm U, Tanasatitchai C, Miyanaga K, Cui L, Ragupathi NKD, Rad SMAH, Khatib A, Storer RJ, Ishikawa H, Amarasiri M, Charuluxananan S, Leelahavanichkul A, Kanjanabuch T, Higgins PG, Davies JC, Stick SM, Kicic A, Chatsuwan T, Shibuya K, Abe S (2025) TesG expression as a potential clinical biomarker for chronic Pseudomonas aeruginosa pulmonary biofilm infections. BMC Med 23(1):191","journal-title":"BMC Med"},{"key":"4526_CR34","doi-asserted-by":"publisher","DOI":"10.3389\/fmicb.2021.682255","volume":"12","author":"X Yang","year":"2021","unstructured":"Yang X, Haque A, Matsuzaki S, Matsumoto T, Nakamura S (2021) The efficacy of phage therapy in a murine model of Pseudomonas aeruginosa pneumonia and sepsis. Front Microbiol 12:682255","journal-title":"Front Microbiol"},{"issue":"3","key":"4526_CR35","doi-asserted-by":"publisher","first-page":"459","DOI":"10.1038\/s41564-018-0322-4","volume":"4","author":"K Zhao","year":"2019","unstructured":"Zhao K, Li W, Li J, Ma T, Wang K, Yuan Y, Li JS, Xie R, Huang T, Zhang Y, Zhou Y, Huang N, Wu W, Wang Z, Zhang J, Yue B, Zhou Z, Li J, Wei Y-Q, Zhang X, Zhou X (2019) TesG is a type i secretion effector of Pseudomonas aeruginosa that suppresses the host immune response during chronic infection. Nat Microbiol 4(3):459\u2013469","journal-title":"Nat Microbiol"}],"container-title":["Archives of Microbiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00203-025-04526-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00203-025-04526-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00203-025-04526-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,20]],"date-time":"2025-11-20T08:05:05Z","timestamp":1763625905000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00203-025-04526-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,18]]},"references-count":35,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2025,12]]}},"alternative-id":["4526"],"URL":"https:\/\/doi.org\/10.1007\/s00203-025-04526-6","relation":{},"ISSN":["0302-8933","1432-072X"],"issn-type":[{"value":"0302-8933","type":"print"},{"value":"1432-072X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,10,18]]},"assertion":[{"value":"27 June 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 October 2025","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 October 2025","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 October 2025","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}},{"value":"The study protocol was approved by the Institutional Review Board (IRB) of the Yamagata Prefectural Central Hospital, Yamagata, Japan (07\/2022). The present article was prepared in compliance with the ARRIVE 2.0 guidelines for reporting animal research.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"We, the authors of this paper, embrace inclusive, diverse, and equitable conduct of research. Our team comprises individuals who self-identify as underrepresented ethnic minorities, gender minorities, members of the LGBTQIA+ community, and individuals living with disabilities. We actively promote gender balance in our reference list while maintaining scientific relevance.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Inclusion and diversity"}}],"article-number":"310"}}